PMC:7102560 / 1082-1711 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T4","span":{"begin":266,"end":272},"obj":"Body_part"},{"id":"T5","span":{"begin":361,"end":366},"obj":"Body_part"},{"id":"T6","span":{"begin":428,"end":433},"obj":"Body_part"},{"id":"T7","span":{"begin":511,"end":517},"obj":"Body_part"}],"attributes":[{"id":"A4","pred":"fma_id","subj":"T4","obj":"http://purl.org/sig/ont/fma/fma228738"},{"id":"A5","pred":"fma_id","subj":"T5","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A6","pred":"fma_id","subj":"T6","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A7","pred":"fma_id","subj":"T7","obj":"http://purl.org/sig/ont/fma/fma228738"}],"text":"Results\nAll 55 patients had a history of epidemiological exposure to COVID-19, and 5 (9%) patients who discharged from hospital presented with SARS-CoV-2 reactivation. Among the 5 reactivated patients, other symptoms were also observed, including fever, cough, sore throat, and fatigue. One of the 5 patients had progressive lymphopenia (from 1.3 to 0.56 × 109 cells per L) and progressive neutrophilia (from 4.5 to 18.28 × 109 cells per L). All 5 reactivated patients presented normal aminotransferase levels. Throat swab samples from the 5 reactivated patients were tested for SARS-CoV-2, indicating all positive for the virus."}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T4","span":{"begin":266,"end":272},"obj":"Body_part"},{"id":"T5","span":{"begin":511,"end":517},"obj":"Body_part"}],"attributes":[{"id":"A4","pred":"uberon_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/UBERON_0000341"},{"id":"A5","pred":"uberon_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/UBERON_0000341"}],"text":"Results\nAll 55 patients had a history of epidemiological exposure to COVID-19, and 5 (9%) patients who discharged from hospital presented with SARS-CoV-2 reactivation. Among the 5 reactivated patients, other symptoms were also observed, including fever, cough, sore throat, and fatigue. One of the 5 patients had progressive lymphopenia (from 1.3 to 0.56 × 109 cells per L) and progressive neutrophilia (from 4.5 to 18.28 × 109 cells per L). All 5 reactivated patients presented normal aminotransferase levels. Throat swab samples from the 5 reactivated patients were tested for SARS-CoV-2, indicating all positive for the virus."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T17","span":{"begin":69,"end":77},"obj":"Disease"},{"id":"T18","span":{"begin":143,"end":151},"obj":"Disease"},{"id":"T19","span":{"begin":143,"end":147},"obj":"Disease"},{"id":"T20","span":{"begin":261,"end":272},"obj":"Disease"},{"id":"T21","span":{"begin":325,"end":336},"obj":"Disease"},{"id":"T22","span":{"begin":579,"end":587},"obj":"Disease"},{"id":"T23","span":{"begin":579,"end":583},"obj":"Disease"}],"attributes":[{"id":"A17","pred":"mondo_id","subj":"T17","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A18","pred":"mondo_id","subj":"T18","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A19","pred":"mondo_id","subj":"T19","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A20","pred":"mondo_id","subj":"T20","obj":"http://purl.obolibrary.org/obo/MONDO_0002258"},{"id":"A21","pred":"mondo_id","subj":"T21","obj":"http://purl.obolibrary.org/obo/MONDO_0003783"},{"id":"A22","pred":"mondo_id","subj":"T22","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A23","pred":"mondo_id","subj":"T23","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"Results\nAll 55 patients had a history of epidemiological exposure to COVID-19, and 5 (9%) patients who discharged from hospital presented with SARS-CoV-2 reactivation. Among the 5 reactivated patients, other symptoms were also observed, including fever, cough, sore throat, and fatigue. One of the 5 patients had progressive lymphopenia (from 1.3 to 0.56 × 109 cells per L) and progressive neutrophilia (from 4.5 to 18.28 × 109 cells per L). All 5 reactivated patients presented normal aminotransferase levels. Throat swab samples from the 5 reactivated patients were tested for SARS-CoV-2, indicating all positive for the virus."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T4","span":{"begin":28,"end":29},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T5","span":{"begin":361,"end":366},"obj":"http://purl.obolibrary.org/obo/GO_0005623"},{"id":"T6","span":{"begin":428,"end":433},"obj":"http://purl.obolibrary.org/obo/GO_0005623"},{"id":"T7","span":{"begin":568,"end":574},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"},{"id":"T8","span":{"begin":623,"end":628},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_10239"}],"text":"Results\nAll 55 patients had a history of epidemiological exposure to COVID-19, and 5 (9%) patients who discharged from hospital presented with SARS-CoV-2 reactivation. Among the 5 reactivated patients, other symptoms were also observed, including fever, cough, sore throat, and fatigue. One of the 5 patients had progressive lymphopenia (from 1.3 to 0.56 × 109 cells per L) and progressive neutrophilia (from 4.5 to 18.28 × 109 cells per L). All 5 reactivated patients presented normal aminotransferase levels. Throat swab samples from the 5 reactivated patients were tested for SARS-CoV-2, indicating all positive for the virus."}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T3","span":{"begin":247,"end":252},"obj":"Phenotype"},{"id":"T4","span":{"begin":254,"end":259},"obj":"Phenotype"},{"id":"T5","span":{"begin":261,"end":272},"obj":"Phenotype"},{"id":"T6","span":{"begin":278,"end":285},"obj":"Phenotype"},{"id":"T7","span":{"begin":325,"end":336},"obj":"Phenotype"},{"id":"T8","span":{"begin":390,"end":402},"obj":"Phenotype"}],"attributes":[{"id":"A3","pred":"hp_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/HP_0001945"},{"id":"A4","pred":"hp_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/HP_0012735"},{"id":"A5","pred":"hp_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/HP_0033050"},{"id":"A6","pred":"hp_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/HP_0012378"},{"id":"A7","pred":"hp_id","subj":"T7","obj":"http://purl.obolibrary.org/obo/HP_0001888"},{"id":"A8","pred":"hp_id","subj":"T8","obj":"http://purl.obolibrary.org/obo/HP_0011897"}],"text":"Results\nAll 55 patients had a history of epidemiological exposure to COVID-19, and 5 (9%) patients who discharged from hospital presented with SARS-CoV-2 reactivation. Among the 5 reactivated patients, other symptoms were also observed, including fever, cough, sore throat, and fatigue. One of the 5 patients had progressive lymphopenia (from 1.3 to 0.56 × 109 cells per L) and progressive neutrophilia (from 4.5 to 18.28 × 109 cells per L). All 5 reactivated patients presented normal aminotransferase levels. Throat swab samples from the 5 reactivated patients were tested for SARS-CoV-2, indicating all positive for the virus."}

{"project":"LitCovid-sentences","denotations":[{"id":"T16","span":{"begin":0,"end":7},"obj":"Sentence"},{"id":"T17","span":{"begin":8,"end":167},"obj":"Sentence"},{"id":"T18","span":{"begin":168,"end":286},"obj":"Sentence"},{"id":"T19","span":{"begin":287,"end":441},"obj":"Sentence"},{"id":"T20","span":{"begin":442,"end":510},"obj":"Sentence"},{"id":"T21","span":{"begin":511,"end":629},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Results\nAll 55 patients had a history of epidemiological exposure to COVID-19, and 5 (9%) patients who discharged from hospital presented with SARS-CoV-2 reactivation. Among the 5 reactivated patients, other symptoms were also observed, including fever, cough, sore throat, and fatigue. One of the 5 patients had progressive lymphopenia (from 1.3 to 0.56 × 109 cells per L) and progressive neutrophilia (from 4.5 to 18.28 × 109 cells per L). All 5 reactivated patients presented normal aminotransferase levels. Throat swab samples from the 5 reactivated patients were tested for SARS-CoV-2, indicating all positive for the virus."}

{"project":"LitCovid-PubTator","denotations":[{"id":"41","span":{"begin":15,"end":23},"obj":"Species"},{"id":"42","span":{"begin":90,"end":98},"obj":"Species"},{"id":"43","span":{"begin":143,"end":153},"obj":"Species"},{"id":"44","span":{"begin":192,"end":200},"obj":"Species"},{"id":"45","span":{"begin":300,"end":308},"obj":"Species"},{"id":"46","span":{"begin":460,"end":468},"obj":"Species"},{"id":"47","span":{"begin":554,"end":562},"obj":"Species"},{"id":"48","span":{"begin":579,"end":589},"obj":"Species"},{"id":"49","span":{"begin":69,"end":77},"obj":"Disease"},{"id":"50","span":{"begin":247,"end":252},"obj":"Disease"},{"id":"51","span":{"begin":254,"end":259},"obj":"Disease"},{"id":"52","span":{"begin":261,"end":272},"obj":"Disease"},{"id":"53","span":{"begin":278,"end":285},"obj":"Disease"},{"id":"54","span":{"begin":325,"end":336},"obj":"Disease"},{"id":"55","span":{"begin":390,"end":402},"obj":"Disease"}],"attributes":[{"id":"A41","pred":"tao:has_database_id","subj":"41","obj":"Tax:9606"},{"id":"A42","pred":"tao:has_database_id","subj":"42","obj":"Tax:9606"},{"id":"A43","pred":"tao:has_database_id","subj":"43","obj":"Tax:2697049"},{"id":"A44","pred":"tao:has_database_id","subj":"44","obj":"Tax:9606"},{"id":"A45","pred":"tao:has_database_id","subj":"45","obj":"Tax:9606"},{"id":"A46","pred":"tao:has_database_id","subj":"46","obj":"Tax:9606"},{"id":"A47","pred":"tao:has_database_id","subj":"47","obj":"Tax:9606"},{"id":"A48","pred":"tao:has_database_id","subj":"48","obj":"Tax:2697049"},{"id":"A49","pred":"tao:has_database_id","subj":"49","obj":"MESH:C000657245"},{"id":"A50","pred":"tao:has_database_id","subj":"50","obj":"MESH:D005334"},{"id":"A51","pred":"tao:has_database_id","subj":"51","obj":"MESH:D003371"},{"id":"A52","pred":"tao:has_database_id","subj":"52","obj":"MESH:D010608"},{"id":"A53","pred":"tao:has_database_id","subj":"53","obj":"MESH:D005221"},{"id":"A54","pred":"tao:has_database_id","subj":"54","obj":"MESH:D008231"},{"id":"A55","pred":"tao:has_database_id","subj":"55","obj":"MESH:C563010"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Results\nAll 55 patients had a history of epidemiological exposure to COVID-19, and 5 (9%) patients who discharged from hospital presented with SARS-CoV-2 reactivation. Among the 5 reactivated patients, other symptoms were also observed, including fever, cough, sore throat, and fatigue. One of the 5 patients had progressive lymphopenia (from 1.3 to 0.56 × 109 cells per L) and progressive neutrophilia (from 4.5 to 18.28 × 109 cells per L). All 5 reactivated patients presented normal aminotransferase levels. Throat swab samples from the 5 reactivated patients were tested for SARS-CoV-2, indicating all positive for the virus."}